Adams Diversified Equity Fund Portfolio holdings
Top Buys
| 1 |
Broadcom
AVGO
|
+$27.1M |
| 2 |
S&P Global
SPGI
|
+$17.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$16.9M |
| 4 |
Boston Scientific
BSX
|
+$16.8M |
| 5 |
SKX
Skechers
SKX
|
+$16.5M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$37.9M |
| 2 |
Synopsys
SNPS
|
+$29.8M |
| 3 |
Apple
AAPL
|
+$23.6M |
| 4 |
Microsoft
MSFT
|
+$23.6M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$22.9M |
Sector Composition
| 1 | Technology | 32.03% |
| 2 | Financials | 12.58% |
| 3 | Healthcare | 11.42% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Communication Services | 9.07% |
Similar funds
Adams Diversified Equity Fund's Q3 2024 Portfolio in Review
As of Q3 2024, Adams Diversified Equity Fund held 113 positions worth $2.72B, down 7.1% from $2.93B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Adams Diversified Equity Fund withdrew a net $347M in Q3 2024, closing 13 positions and reducing 61 holdings. Its most notable exit was Advanced Micro Devices, an estimated $37.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Adams Diversified Equity Fund opened a new position in S&P Global worth $17.9M.
- Adams Diversified Equity Fund's largest Q3 2024 buy was S&P Global: 34,700 shares worth $17.9M.
- Adams Diversified Equity Fund added most to Broadcom in Q3 2024, an estimated $27.1M increase.
- Adams Diversified Equity Fund's biggest Q3 2024 reduction was Apple, cutting an estimated $23.6M.
- Adams Diversified Equity Fund fully exited Advanced Micro Devices in Q3 2024, selling an estimated $37.9M.
- Adams Diversified Equity Fund's ten largest holdings make up 40% of its $2.72B portfolio in Q3 2024.
- Adams Diversified Equity Fund opened 16 new positions and closed 13 in Q3 2024.
- Adams Diversified Equity Fund's portfolio value fell 7.1% quarter-over-quarter to $2.72B.
Based on Adams Diversified Equity Fund's 13F filing for Q3 2024, filed 25 Oct 2024.